Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer: Original article: Clinical investigation

International Journal of Urology

Volumn 17, Issue 3, 2010, Pages 254-258

  Okegawa, Takatsugu ^a   Hayashi, Kenjiro ^a   Hara, Hidehiko ^a   Nutahara, Kikuo ^a   Higashihara, Eiji ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

CellSearch System; Circulating tumor cells; Urothelial cancer

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; TUMOR MARKER;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BONE METASTASIS; CANCER CELL CULTURE; CELL ASSAY; CELL COUNT; CELL SEPARATION; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; LINEAR SYSTEM; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; RELIABILITY; STAINING; TUMOR CELL; URINARY TRACT CANCER; UROTHELIUM; UROTHELIUM CANCER;

AGED; BONE NEOPLASMS; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASTIC CELLS, CIRCULATING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 77749267716     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02454.x     Document Type: Article

References (19)

1. Okegawa T, Noda H, Kato M, Miyata A, Nutahara K, Higashihara E. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer. Prostate 2000 44 : 210 218.
2. Loberg RD, Fridman Y, Pienta BA et al. Detection and isolation of circulating tumor cells in urologic cancers: a review. Neoplasia 2004 6 : 302 309.
3. Ross RW, Manola J, Hennessy K et al. Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy. Clin. Cancer Res. 2005 11 : 5195 5198.
4. Ghossein RA, Rosai J, Scher HI et al. Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostate carcinoma. Urology 1997 50 : 100 105.
5. Kagan M, Howard D, Bendele T et al. A sample preparation and analysis system for identification of circulating tumor cells. J. Clin. Ligand. Assay 2002 25 : 104 110.
6. Moreno JG, Miller MC, Gross S, Allard WJ, Gomella LG, Terstappen LW. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 2005 65 : 713 718.
7. Garcia JA, Rosenberg JE, Weinberg V et al. Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer. BJU Int. 2007 99 : 519 524.
8. Danila DC, Heller G, Gignac GA et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin. Cancer Res. 2007 13 : 7053 7058. (Pubitemid 350276887)
9. Okegawa T, Nutahara K, Higashihara E. Immunomagnetic quantification of circulating tumors cell as a prognostic factor of androgen-deprivation responsiveness in hormone-naive metastatic prostate cancer patients. J. Urol. 2008 180 : 1342 1347.
10. Shaffer DR, Leversha MA, Danila DC et al. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin. Cancer Res. 2007 13 : 2023 2029.
11. Chen BT, Loberg RD, Neeley CK et al. Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease. Urology 2005 65 : 616 621.
12. de Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 2008 14 : 6302 6309.
13. Scher HI, Jia X, de Bono JS et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol. 2009 10 : 233 239.
14. Cristofanilli M, Budd GT, Ellis MJ et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004 351 : 781 791.
15. Cristofanilli M, Gonzalez-Angulo A, Sneige N et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol. 2005 23 : 1420 1430.
16. Hiraiwa K, Takeuchi H, Hasegawa H et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann. Surg. Oncol. 2008 15 : 3092 3100.
17. Naoe M, Ogawa Y, Morita J et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 2007 109 : 1439 1445.
18. Gallagher DJ, Milowsky MI, Ishill N et al. Detection of circulating tumor cells in patients with urothelial cancer. Ann. Oncol. 2009 20 : 305 308.
19. Naoe M, Ogawa Y, Takeshita K, Iwamoto S, Miyazaki A. Use of the CellSearch Circulating Tumor Cell Test for monitoring urothelial cancer: two case reports of metastatic urothelial cancer. South. Med. J. 2008 101 : 439 441.